Paul Virgo
Overview
Explore the profile of Paul Virgo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas A, Halliday A, Clapp G, Symonds R, Hopewell-Kelly N, McGrath C, et al.
Zoonoses Public Health
. 2025 Feb;
PMID: 40007044
Background: Between 1999 and 2021, 505 culture-confirmed cases of M. bovis disease in humans (zoonotic tuberculosis, TB) were diagnosed in England. We aimed to estimate the prevalence of M. bovis...
2.
Kelleher P, Greathead L, Whitby L, Brando B, Barnett D, Bloxham D, et al.
Cytometry B Clin Cytom
. 2024 Jun;
106(6):424-436.
PMID: 38940298
Over the last 15 years activity of diagnostic flow cytometry services have evolved from monitoring of CD4 T cell subsets in HIV-1 infection to screening for primary and secondary immune...
3.
Horgan C, Mullanfiroze K, Rauthan A, Patrick K, Butt N, Mirci-Danicar O, et al.
Blood Adv
. 2023 Jan;
7(10):2155-2165.
PMID: 36649566
Stem cell transplant (SCT) outcomes in high-risk and relapsed/refractory (R/R) pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have been historically poor. Cord blood (CB) allows T-cell replete CB...
4.
Tandon S, Visser R, Astwood E, Payne J, Gray J, Wheeler L, et al.
Br J Haematol
. 2021 Oct;
196(3):e34-e39.
PMID: 34658015
No abstract available.
5.
Cordoba S, Onuoha S, Thomas S, Pignataro D, Hough R, Ghorashian S, et al.
Nat Med
. 2021 Oct;
27(10):1797-1805.
PMID: 34642489
Chimeric antigen receptor (CAR) T cells targeting CD19 or CD22 have shown remarkable activity in B cell acute lymphoblastic leukemia (B-ALL). The major cause of treatment failure is antigen downregulation...
6.
Wong N, Wallage M, Virgo P, Lowes H
J Clin Pathol
. 2021 Jan;
75(3):205-208.
PMID: 33509947
Aims And Methods: Faecal calprotectin (FCP) measurement is used especially to investigate for inflammatory bowel disease (IBD). To assess the utility of sampling endoscopically normal large bowel among patients first...
7.
Freeman S, Hills R, Virgo P, Khan N, Couzens S, Dillon R, et al.
J Clin Oncol
. 2018 Mar;
36(15):1486-1497.
PMID: 29601212
Purpose We investigated the effect on outcome of measurable or minimal residual disease (MRD) status after each induction course to evaluate the extent of its predictive value for acute myeloid...
8.
De Fonseka D, Arnold D, Stadon L, Morley A, Keenan E, Darby M, et al.
BMC Cancer
. 2018 Feb;
18(1):199.
PMID: 29454314
Background: Radiological monitoring of malignant pleural mesothelioma (MPM) using modified RECIST criteria is limited by low sensitivity and inter-observer variability. Serial serum mesothelin measurement has shown utility in the assessment...
9.
Quek L, Otto G, Garnett C, Lhermitte L, Karamitros D, Stoilova B, et al.
J Exp Med
. 2016 Jul;
213(8):1513-35.
PMID: 27377587
Our understanding of the perturbation of normal cellular differentiation hierarchies to create tumor-propagating stem cell populations is incomplete. In human acute myeloid leukemia (AML), current models suggest transformation creates leukemic...
10.
Khan N, Freeman S, Virgo P, Couzens S, Richardson P, Thomas I, et al.
Br J Haematol
. 2015 Apr;
170(1):80-4.
PMID: 25876768
Many older patients with acute myeloid leukaemia (AML) that receive standard intensive chemotherapy fail to achieve complete remission (CR). Upfront identification of patients unlikely to benefit from standard induction chemotherapy...